The latest trading session saw Teladoc (TDOC) ending at $7.25, denoting a +0.83% adjustment from its last day's close. The stock's performance was ahead of the S&P 500's daily gain of 0.45%. Elsewhere, the Dow lost 0.23%, while the tech-heavy Nasdaq added 0.84%. Shares of the telehealth services provider witnessed a gain of 4.66% over the previous month, beating the performance of the Medical sector with its gain of 3.16% and the S&P 500's gain of 2.54%. Analysts and investors alike will be keeping a close ...

Shares of Teladoc Health, Inc. (TDOC) have dropped 31.2% over the past three months to close at $7.19 on Monday, near its 52-week low of $6.76. Having underperformed its industry and the S&P 500, the company's current share price seems an excellent opportunity to build a position in a renowned company - after all, you would much rather buy closer to the low than the high, right? TDOC's Three-Month Price Performance Image Source: Zacks Investment Research Let's now take a close look at Teladoc, with an eye o ...

PURCHASE, NY, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued an inducement award to a new employee. Effective September 1, 2024, in connection with commencing employment as Senior Vice President of Product, BetterHelp, Terre Layton was granted an award of restricted stock units covering 50,000 shares of Teladoc Health's common stock, par value $0.001 per share. The restricted stock units vest, based on conti ...

The most recent trading session ended with Teladoc (TDOC) standing at $7.17, reflecting a +0.99% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's daily gain of 1.01%. Elsewhere, the Dow saw an upswing of 0.55%, while the tech-heavy Nasdaq appreciated by 1.13%. Prior to today's trading, shares of the telehealth services provider had lost 17.35% over the past month. This has lagged the Medical sector's gain of 4.91% and the S&P 500's gain of 2.5% in that time. A ...

Teladoc Health boasts substantial strengths and is positioned for enhanced performance, but according to new CEO Chuck Divita, there is work to do. "The company has many strengths to build upon and to drive higher levels of execution and performance," he said during the company's second-quarter earnings call, but added, "This is a company that is not yet delivering on its fullest potential." Divita, who took over as CEO in June, recently interacted with employees and stakeholders and praised the company's c ...

The telehealth stock's prospects look dim. It seems so long ago that Teladoc Health (TDOC 0.71%) was a bit of a market darling. The telemedicine specialist shot to prominence when its services were in high demand -- during the heat of the pandemic -- but it's been pretty much downhill since then. Teladoc's latest financial results did nothing to help, as the company once again disappointed investors (more on that below). Could Teladoc turn things around? Is it worth it to buy the stock at current levels? Te ...

Adam Gault We previously covered Teladoc (NYSE:TDOC) in May 2024, discussing why we had maintained our Hold (Neutral) rating, with the management reporting underwhelming performance metrics in FQ1'24 and numerous other players throwing in the towel on their telehealth ambitions. With bullish support yet to materialize, the insider selling intensifying, and with the stock increasingly shorted, we had believed that its reversal had been highly speculative. Since then, TDOC continues to underperform, with the ...

Teladoc Health, Inc.'s (TDOC) shares lost 8.9% since it reported second-quarter 2024 results on Jul 31, despite an earnings beat. Investors might be worried about BetterHelp's substantial revenue drop, leading to a decline in its adjusted EBITDA. Moreover, the withdrawal of full-year guidance for BetterHelp and the lack of consolidated guidance for the rest of the year added to the uncertainty. Strength in the Integrated Care segment acted as a partial offset. The company incurred a second-quarter 2024 adju ...

Henrik Sorensen/DigitalVision via Getty Images Investment Overview The last time I provided coverage of Teladoc Health, Inc. (NYSE:TDOC), the Purchase, New York-based virtual healthcare/telemedicine provider, it was in 2023, and I gave the company's stock a "sell" rating with shares trading at $17. Today, they are priced at $8.7 a share (at the time of writing), down nearly 50%. This is one of the easier calls I have made in notes for Seeking Alpha covering the healthcare, pharma, and biotech industries. Ev ...

I thought Teladoc stock might be a buy. I was wrong -- and capitalized software costs are the reason why. Teladoc Health (TDOC -5.25%) stock, the telemedicine specialist that made the controversial decision to spend $18.5 billion on diabetes care company Livongo in 2020, reported more bad news last night, sending shares down 8.7% through 10 a.m. ET. Analysts following Teladoc forecast the company would report quarterly losses of $0.35 per share on sales of $649.6 million. As it turned out, the news was even ...